Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
76.17
+0.67 (0.89%)
Aug 12, 2026, 11:04 AM EDT - Market open

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Applying our Expertise to Develop Novel Drug Candidates
55.23M98.43M90.12M92.06M101.91M
Total
55.23M98.43M90.12M92.06M101.91M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
-1.38M11.48M9.84M10.11M
Rest of World
55.23M97.05M78.64M82.21M91.79M
Total
55.23M98.43M90.12M92.06M101.91M